Do the IDF and NCEP ATP III definitions of the metabolic syndrome accurately predict coronary heart disease in subjects with type 2 diabetes?
The IDF definition of metabolic syndrome may not be an effective tool for identifying the highest risk subgroup for coronary heart disease in patients who already have established type 2 diabetes.
With established type 2 diabetes, the IDF definition of the metabolic syndrome failed to identify a subgroup of patients who had the highest risk for CHD. Practitioners must recognize the appropriate setting for its application.
Tong et al. (Fri,) studied this question.